Improvements in metabolic markers often emerge over 60 to 72 weeks, though stopping therapy abruptly may lead to gradual weight regain, reinforcing the need for tapering and behavioural adaptation
Thirty percent of participants, however, showed a significant improvement in objective behavioural measures which correlated with improved plasma GSH and GSH:GSSG levels
These side effects usually improve over time and can be managed with dietary changes, drinking plenty of fluids, and over-the-counter medications if necessary
It has also been shown to stabilize blood sugar levels which plays an important role in managing cravings
The three receptors do not just add up
By offering improved glycemic control, cardiovascular health, liver benefits, appetite regulation, and psychological well-being, these medications exemplify the future of integrated healthcare solutions